Your session is about to expire
← Back to Search
Ketorolac for Blood Vessel Function (VDR Trial)
VDR Trial Summary
This trial is studying whether ketorolac, an IV NSAID, can reduce the response of the muscle sympathetic nerve to limb venous distention.
VDR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVDR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VDR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand the study and can agree to participate.My medical history and physical exam meet the trial's requirements.I am either younger than 21 or older than 35.I am on medication that could impact my heart or nervous system.I have a chronic condition like heart disease or diabetes.I have had stomach ulcers or bleeding in the past.I weigh more than 50 kg.I have not taken NSAIDs within 48 hours before my visit.I am between 21 and 35 years old.I do not have any ongoing serious health issues.
- Group 1: Ketorolac
- Group 2: Control
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom is eligibility for this medical experiment available?
"Eligibility requirements to partake in this trial include age (between 21 and 35) as well as a healthy blood pressure. A total of 18 participants will be welcomed into the study."
Have there been any other investigations into the effects of Wrist-to-elbow (W-E) occlusion?
"At present, there are 38 ongoing trials that investigate Wrist-to-elbow (W-E) occlusion with 8 of them being in their third phase. The investigations take place across 57 sites located mainly in Los Angeles, California."
What is the aggregate count of participants enrolled in this trial?
"The data on clinicaltrials.gov validates that this medical study is recruiting at the moment. It was first listed online on August 14th 2019, and last updated January 10th 2022. The trial requires 18 individuals to participate via one site only."
Are participants aged 50 and above being accepted for this clinical trial?
"This trial has a restricted age range of 21 to 35 years old. There are 24 additional studies for minors and 131 trials available for seniors aged 65 or older."
What is the overarching purpose of this clinical trial?
"This medical trial's primary outcome, observed over a span of three to four hours, is the measurement of vein size using MRI imaging. Secondary objectives include non-invasive skin blood flow measurements with laser-Doppler flowmetry, various EKG readings for heart rate monitoring and strain gauge evaluations which measure changes in circumference levels on the forearm."
Is there currently an opportunity for patients to register for this research?
"Indeed. According to clinicaltrials.gov, this medical study is still accepting participants - it was first posted on August 14th 2019 and the listing has been recently updated as of January 10th 2022. Currently, 18 volunteers are required for a single location."
What medical conditions can be addressed through the use of Wrist-to-elbow (W-E) occlusion?
"Wrist-to-elbow occlusion is traditionally used to combat ocular itching, but can also offer relief from pain, induce a nerve block, and alter pupil size."
Share this study with friends
Copy Link
Messenger